Inflammatory pathways and anti‐inflammatory therapies in sickle cell disease
Abstract Sickle cell disease (SCD) is a monogenic disease, resulting from a single‐point mutation, that presents a complex pathophysiology and high clinical heterogeneity. Inflammation stands as a prominent characteristic of SCD. Over the past few decades, the role of different cells and molecules i...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|